These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31044518)

  • 21. [Abuse potential during use and withdrawal psychosis after treatment with the hypnotic zolpidem (Stilnoct)].
    Bruun TG
    Ugeskr Laeger; 1993 Aug; 155(35):2711-3. PubMed ID: 7786333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Abuse of and dependence on zolpidem: a report of seven cases].
    Courtet P; Pignay V; Castelnau D; Boulenger JP
    Encephale; 1999; 25(6):652-7. PubMed ID: 10668611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medicines associated with dependence or withdrawal: a mixed-methods public health review and national database study in England.
    Marsden J; White M; Annand F; Burkinshaw P; Carville S; Eastwood B; Kelleher M; Knight J; O'Connor R; Tran A; Willey P; Greaves F; Taylor S
    Lancet Psychiatry; 2019 Nov; 6(11):935-950. PubMed ID: 31588045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What's wrong with prescribing hypnotics?
    Drug Ther Bull; 2004 Dec; 42(12):89-93. PubMed ID: 15587763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Main neuroendocrine features and therapy in primary sleep troubles.
    Amihăesei IC; Mungiu OC
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):862-6. PubMed ID: 23272543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zolpidem dependence in a patient with former polysubstance abuse.
    Bottlender R; Schütz C; Möller HJ; Soyka M
    Pharmacopsychiatry; 1997 May; 30(3):108. PubMed ID: 9211573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.
    Holm KJ; Goa KL
    Drugs; 2000 Apr; 59(4):865-89. PubMed ID: 10804040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dependence and tolerance with zolpidem.
    Sánchez LG; Sanchez JM; Lopez Moreno J
    Am J Health Syst Pharm; 1996 Nov; 53(21):2638. PubMed ID: 8913396
    [No Abstract]   [Full Text] [Related]  

  • 29. Zolpidem self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons.
    Weerts EM; Griffiths RR
    Behav Pharmacol; 1998 May; 9(3):285-97. PubMed ID: 9832941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rebound insomnia and newer hypnotics.
    Lader M
    Psychopharmacology (Berl); 1992; 108(3):248-55. PubMed ID: 1523276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Handgrip strength and balance in older adults following withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotics.
    Nurminen J; Puustinen J; Lähteenmäki R; Vahlberg T; Lyles A; Partinen M; Räihä I; Neuvonen PJ; Kivelä SL
    BMC Geriatr; 2014 Nov; 14():121. PubMed ID: 25416480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Abuse, tolerance and dependence of zolpidem: three case reports].
    Correas Lauffer J; Braquehais Conesa D; Barbudo Del Cura E; Ochoa Mangada E
    Actas Esp Psiquiatr; 2002; 30(4):259-62. PubMed ID: 12217277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zolpidem physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons.
    Weerts EM; Ator NA; Grech DM; Griffiths RR
    J Pharmacol Exp Ther; 1998 Apr; 285(1):41-53. PubMed ID: 9535993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term persistence of withdrawal of temazepam, zopiclone, and zolpidem in older adults: a 3-year follow-up study.
    Puustinen J; Lähteenmäki R; Nurminen J; Vahlberg T; Aarnio P; Partinen M; Räihä I; Neuvonen PJ; Kivelä SL
    BMC Geriatr; 2018 Jun; 18(1):142. PubMed ID: 29907085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of parenteral zolpidem dependence with opioid-like withdrawal symptoms.
    Kao CL; Huang SC; Yang YJ; Tsai SJ
    J Clin Psychiatry; 2004 Sep; 65(9):1287. PubMed ID: 15367062
    [No Abstract]   [Full Text] [Related]  

  • 36. Abuse, dependence, and epileptic seizures after zolpidem withdrawal: review and case report.
    Aragona M
    Clin Neuropharmacol; 2000; 23(5):281-3. PubMed ID: 11154097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BDZs, Designer BDZs and Z-drugs: Pharmacology and Misuse Insights.
    Zaami S; Graziano S; Tittarelli R; Beck R; Marinelli E
    Curr Pharm Des; 2022; 28(15):1221-1229. PubMed ID: 34533440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term benzodiazepine and Z-drugs use in England: a survey of general practice [corrected].
    Davies J; Rae TC; Montagu L
    Br J Gen Pract; 2017 Sep; 67(662):e609-e613. PubMed ID: 28716996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Zolpidem dependence and depression in the elderly].
    Thome J; Ruchsow M; Rösler M; Becker T
    Psychiatr Prax; 1995 Jul; 22(4):165-6. PubMed ID: 7675909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacological profile and clinical effect of zolpidem (Myslee tablets), a hypnotic agent].
    Shirakawa K
    Nihon Yakurigaku Zasshi; 2002 Feb; 119(2):111-8. PubMed ID: 11862759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.